Seragon Biosciences Concludes SRN-901’s Pre-Clinical Study to Evaluate its Effect on Aging
Shots: Seragon has concluded the pre-clinical study of SRN-901 to assess its effec...
Shots: Seragon has concluded the pre-clinical study of SRN-901 to assess its effec...
Shots: Mozart highlighted pre-clinical results of KIR x ICOS bispecific Ab targeti...
Shots: Seismic presented the preclinical data of S-1117, Fc-fused pan-IgG protease...
Shots: Merus highlighted preclinical results of zenocutuzumab, HER2 × HER3 b...
Shots: Coherus’ presentation was titled as,
Shots: Microbot Medical concludes its pivotal GLP pre-clinical study in porcine mo...
Incisive News in 3 Shots.